This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of pharmacologically active molecules. Its structure is particularly relevant in the development of compounds targeting the central nervous system, as it contains functional groups that interact with neurotransmitter receptors. Researchers often explore its potential in creating drugs for neurological disorders such as Parkinson's disease, schizophrenia, or other conditions involving dopamine receptor modulation. Additionally, its fluorophenethyl moiety makes it a candidate for further derivatization to enhance binding affinity or selectivity towards specific biological targets. The compound is also of interest in the study of structure-activity relationships (SAR) to optimize drug efficacy and reduce side effects.